Unbound MEDLINE

The effect of a peptide aldehyde reversible inhibitor of elastase on a human leucocyte elastase-induced model of emphysema in the hamster. European journal of respiratory diseases. [Eur J Respir Dis] Journal article

 
TitleThe effect of a peptide aldehyde reversible inhibitor of elastase on a human leucocyte elastase-induced model of emphysema in the hamster.
Author(s)Kennedy AJ, Cline A, Ney UM, Johnson WH, Roberts NA 
InstitutionDepartment of Biology, Roche Products Ltd, Welwyn Garden City, U.K.
SourceEur J Respir Dis 1987 Nov; 71(5):472-8.
MeSHAdamantane
Animals
Cricetinae
Disease Models, Animal
Leukocyte Elastase
Lung
Lung Compliance
Male
Mesocricetus
Oligopeptides
Pancreatic Elastase
Pulmonary Emphysema
Respiratory Function Tests
AbstractThe peptide aldehyde Ro 31-3537, N alpha-(1-adamantanesulphonyl)-N epsilon-(4-carboxybenzoyl)-L-lysyl-L-alanyl-L- valinal, is a reversible competitive, hydrophilic, specific inhibitor of elastase. Its Ki against human leucocyte elastase is 6 x 10(-8) M. The effect of this compound has been studied on a model of emphysema in the hamster induced by multiple sequential intratracheal doses of human leucocyte elastase. Concomitant intratracheal dosing of 200 micrograms of inhibitor with the enzyme significantly reduces lung damage as measured by quasi-static lung compliance and by histological assessment of the emphysema.
Languageeng
Pub Type(s)Journal Article
PubMed ID3443167
  
Advertise on this site.